Aptorum Group Ltd — Investor Relations & Filings
Aptorum Group Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to address unmet medical needs. The company's research and development pipeline targets a range of therapeutic areas, including orphan oncology, infectious diseases, and metabolic diseases. Key projects include SACT-1, a repurposed drug candidate for neuroblastoma, and ALS-4, an anti-virulence, non-bactericidal therapeutic for infections caused by Staphylococcus aureus. Additionally, the company is developing its RPIDD (Rapid Pathogen Identification and Detection Diagnostics) platform, a liquid biopsy-based technology for rapidly identifying and detecting pathogens.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 20-F - Aptorum Group Ltd (0001734005) (Filer) | 2026-03-27 | English | |
| 6-K Filing | 2026-02-06 | English | |
| S-4/A Filing | 2026-01-21 | English | |
| REGISTRATION STATEMENT | 2026-01-16 | English | |
| PROSPECTUS SUPPLEMENT | 2025-12-05 | English | |
| AMENDMENT NO. 1 TO FORM 6-K | 2025-12-05 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 33065447 | 20-F - Aptorum Group Ltd (0001734005) (Filer) | 2026-03-27 | English | ||
| 31520173 | 6-K Filing | 2026-02-06 | English | ||
| 31520178 | S-4/A Filing | 2026-01-21 | English | ||
| 13097379 | REGISTRATION STATEMENT | 2026-01-16 | English | ||
|
2025
11 filings
| |||||
| 13097380 | PROSPECTUS SUPPLEMENT | 2025-12-05 | English | ||
| 13097381 | AMENDMENT NO. 1 TO FORM 6-K | 2025-12-05 | English | ||
| 13097382 | Regulatory Filings 2025 | 2025-12-04 | English | ||
| 13097383 | DEL AM | 2025-11-18 | English | ||
| 13097384 | REGISTRATION STATEMENT | 2025-11-17 | English | ||
| 13097385 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-16 | English | ||
| 13097386 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-15 | English | ||
| 13097387 | PROSPECTUS SUPPLEMENT | 2025-10-14 | English | ||
| 13097388 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-08 | English | ||
| 13097390 | REGISTRATION STATEMENT | 2025-10-06 | English | ||
| 13097389 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-03 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IBEX TECHNOLOGIES INC.
Develops and manufactures high-purity enzymes and specializ…
|
IBT | CA | Manufacturing |
|
iBio, Inc.
Preclinical biotech using an AI platform to develop antibod…
|
IBIO | US | Manufacturing |
|
Icure Pharmaceutical Incorporation
A biopharmaceutical firm specializing in Transdermal Drug D…
|
175250 | KR | Manufacturing |
|
ID Biomedical Corporation
Researched, developed, and manufactured innovative vaccines…
|
IDBE | CA | Manufacturing |
|
IDEAYA Biosciences, Inc.
Clinical-stage oncology company developing targeted therapi…
|
IDYA | US | Manufacturing |
|
Idorsia Ltd
Biopharmaceutical company developing small-molecule medicin…
|
IDIA | CH | Manufacturing |
|
IDT AUSTRALIA LIMITED
Specializes in high-potency API development and manufacturi…
|
IDT | AU | Manufacturing |
|
ILDONG HOLDINGS CO.,LTD
A holding company managing a diversified healthcare group i…
|
000230 | KR | Manufacturing |
|
IL DONG PHARMACEUTICAL CO., LTD.
Develops, manufactures, and commercializes a broad range of…
|
249420 | KR | Manufacturing |
|
ILSUNG IS CO., LTD.
Develops and manufactures antibiotics, cardiovascular agent…
|
003120 | KR | Manufacturing |
Aptorum Group Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35125/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35125 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35125 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35125 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35125}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aptorum Group Ltd (id: 35125)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.